Annual General Meeting 2020

3According to the Public Health Agency of Sweden, there is now a general spread of the coronavirus in Sweden. In view of this, Sprint Bioscience AB (publ) wants to limit the risk of infection and therefore urges people who are part of the risk groups, ie. people who are over 70 years old or have a deteriorating state of health, as well as people who do not feel healthy, to stay at home. Sprint Bioscience AB (publ) attaches great importance to safeguarding the health of both its shareholders and employees and therefore wishes that the above guidelines are respected.

 In order to minimize the number of participants at the meeting, Sprint Bioscience AB (publ) encourages its shareholders not to attend in person but instead to take advantage of the opportunity to vote by proxy. Power of attorney and information for appointing a proxy is available here on the page.

 Sprint Bioscience AB (publ) would also like to limit the number of assistants to the Annual General Meeting as much as possible to keep the number of participants down.

 Sprint Bioscience AB (publ) will also take additional measures at the Annual General Meeting to minimize the risk of potential spread of infection. The AGM will be kept as short as possible, which means that planned speeches will be limited, external guests will not be invited and the participation of both board members and company management will be limited.

Sprint Bioscience AB (publ) is following the development of events very closely and will, if necessary, update precautionary measures before the Annual General Meeting. For current information on the coronavirus, we refer to the Public Health Agency's website, www.folkhalsomyndigheten.se

(The full text of the invitation can be found in Press releases and as a PDF on this page)

"Notice of Annual General Meeting in Sprint Bioscience AB (publ)

The shareholders of Sprint Bioscience AB (publ), reg. no. 556789-7557 with registered office in Stockholm, are hereby invited to the Annual General Meeting on Wednesday, May 13, 2020 at 16.00 at Novum, Hälsovägen 7, 141 57 Huddinge. Voting registration begins at 15.30 and is interrupted when the meeting opens.

Right to participate in the General Meeting

Shareholders wishing to attend the General Meeting shall in part be entered in the share register maintained by Euroclear Sweden AB on Thursday, May 7, 2020, in part register with the company no later than Thursday, May 7, 2020.

Notification shall be made by letter to Sprint Bioscience AB (publ), Att: Annual General Meeting 2020, Novum, 141 57 Huddinge or by e-mail to info@sprintbioscience.com. When registering, name, personal/corporate identity number, shareholding, address, telephone number and information about any advisors (maximum two) and, where applicable, information about proxies must be stated.

Ombudsmen

Shareholders represented by proxy must issue a dated power of attorney for the proxy. If the power of attorney is issued by a legal entity, a certified copy of the certificate of registration or equivalent for the legal entity must be attached. The power of attorney and any certificate of registration may not be older than one year, however, the power of attorney may be older if it is valid for a longer period of time, maximum five years. The original power of attorney and any certificate of registration should be sent to the company at the above address or by e-mail to the above e-mail address in good time before the meeting. A proxy form is available on the company's website, www.sprintbioscience.com, and will also be sent to shareholders who so request and who provide their postal address.

Nominee-registered shares

Shareholders whose shares are registered in the name of a nominee through a bank or securities institution must temporarily re-register the shares in their own name in order to be entitled to participate in the meeting. Such registration must be completed at Euroclear Sweden AB on Thursday, May 7, 2020, which means that the shareholder must inform the nominee well in advance of this date. "